Literature DB >> 21063528

Desmoplastic melanoma presenting as pyogenic granuloma: report of a case with review of literature.

B Venkata Ratnam1.   

Abstract

An elderly female patient was referred to the author for the treatment of a large recurrent pyogenic granuloma in the sole of right foot for a period of 2 years. She underwent excisional surgeries at an outside facility twice in the past. This time, she was treated with wide excision biopsy and the surgical defect was closed with a new technique, the "adjustable suture technique". Histopathology report confirmed "desmoplastic melanoma" with complete marginal clearance. The wound had healed uneventfully. There were no recurrences at 4-year follow-up.

Entities:  

Keywords:  Desmoplastic melanoma; pyogenic granuloma; resemblance

Year:  2010        PMID: 21063528      PMCID: PMC2965922          DOI: 10.4103/0019-5154.70706

Source DB:  PubMed          Journal:  Indian J Dermatol        ISSN: 0019-5154            Impact factor:   1.494


Introduction

Conditions without characteristic clinical features, especially if they are rare, can lead to incorrect diagnoses and management. The consequences could be fatal, but might be preventable with a high index of suspicion that follows familiarity with the condition. To the author’s knowledge, desmoplastic melanoma, a rare and disastrous malignancy, presenting as pyogenic granuloma, a common and benign condition, has not been reported yet. This study reports one such case that had misled the treating doctors repeatedly.

Case Report

This article reports the case of an elderly woman who presented with a painless growth that used to bleed on touch in the sole of her right foot for a period of two years. It was excised twice earlier elsewhere. The details of the earlier presentation, surgery, or histopathology were not available. It resembled a large pyogenic granuloma at the junction of instep sole and weight-bearing heel [Figure 1]. There was no similar lesion elsewhere in the body, and there was no evidence of regional or systemic involvement. During a wide excision biopsy procedure, a soft, pigmented nodule of about 1 × 1 cm size was noted in the subcutaneous tissue [Figure 2], which was also included in the specimen. The resultant defect was directly closed in fourteen days’ period using the “adjustable suture technique,” a type of external tissue expansion, initiated by the author.[1]
Figure 1

Desmoplastic melanoma appearing as a large pyogenic granuloma

Figure 2

The pigmented soft tissue nodule in the subcutaneous tissue (arrow)

Desmoplastic melanoma appearing as a large pyogenic granuloma The pigmented soft tissue nodule in the subcutaneous tissue (arrow) At four-year follow-up, the wound had healed well and the scar was stable. There was no evidence of local recurrence. Systemic survey and hematological and whole-body CT scanning at four-year follow-up were negative for metastases.

Histopathology

Separate Hematoxylin and Eosin stained sections from each lesion, the intervening tissue, and the surrounding tissues were examined microscopically.

The main lesion

It showed extensively ulcerated epidermis, covered by necrotic debris and fibrinoid exudates. It had infiltrative and expansile growth patterns in the dermis, extending into the subcutaneous tissue. It mainly consisted of two populations of cells given as follows: (i) The spindle cell population was predominant [Figure 3]. These cells were arranged in swirling fascicles, nests, and bundles exhibiting firoblast-like features. They had elongated, fusiform nuclei and showed mild to moderate degree of pleomorphism. Occasional foci of cells showed perivascular cuffing. In addition, focal storiform-areas, reminiscent of dermatofibrosarcoma protuberans (DFSP) and haemangiopericytoma-like (HPC-like) areas were also found [Figure 4]. The tumor cell mitoses were frequent, being about 30–35/10 high power fields [Figure 5]. (ii) The second cell type was the epithelioid cells [Figures 6 and 7]. They were present in nests and alveolar formations with vesiculated ovoid nuclei [Figure 7]. No cells contained melanin pigment in them. A moderate amount of lymphoplasmacytic infiltrate was present in the stroma [Figure 3]. The lesion was present at Clark’s level V and Breslow’s thickness of 8 mm, with microscopic evidence of all margins of surgical resection appearing free of tumor infiltration.
Figure 3

Intradermal location of tumor consisting mainly of spindle cells (vertical arrows) and lymphoplasmacytic infiltration (horizontal arrows) (H and E stain, ×50)

Figure 4

Tumor cells arranged in swirling fascicles reminiscent of DFSP (arrows) (H and E stain, ×100)

Figure 5

Spindle cells showing intense mitotic activity (arrows) (H and E stain, ×400)

Figure 6

Another area of same tumor showing epithelioid nature of the tumor cells (arrows) (H and E stain, ×100)

Figure 7

Epithelioid tumor cells with large vesicular nuclei and prominent nucleoli and eosinophilic cytoplasm (H and E stain, ×400)

Intradermal location of tumor consisting mainly of spindle cells (vertical arrows) and lymphoplasmacytic infiltration (horizontal arrows) (H and E stain, ×50) Tumor cells arranged in swirling fascicles reminiscent of DFSP (arrows) (H and E stain, ×100) Spindle cells showing intense mitotic activity (arrows) (H and E stain, ×400) Another area of same tumor showing epithelioid nature of the tumor cells (arrows) (H and E stain, ×100) Epithelioid tumor cells with large vesicular nuclei and prominent nucleoli and eosinophilic cytoplasm (H and E stain, ×400)

The second lesion

It consisted of small-to moderate-sized cells with small, round nuclei, arranged in alveolar formations and nests [Figure 8]. No spindle cells were seen. A small proportion of these cells showed pale-brown, melanin pigment in their cytoplasm. A moderate amount of lymphoplasmacytic infiltrate was present in its stroma.
Figure 8

Satellite lesion consisting predominantly of epithelioid tumor cells on the right and fibrous intervening stroma on the left (H and E stain, ×50)

Satellite lesion consisting predominantly of epithelioid tumor cells on the right and fibrous intervening stroma on the left (H and E stain, ×50)

The fibro-fatty subcutaneous tissue between the two lesions

It was free of tumor cells [Figure 8].

Immunohistochemistry

The tumor cells in both the lesions showed diffuse positivity for S-100 [Figure 9] and vimentin [Figure 10], but negativity for cytokeratin [Figure 11]. The cells of the second lesion showed generalized positivity for HMB-45 [Figure 12], but this finding was scanty in the cells of the main lesion.
Figure 9

Immunohistochemical staining for S100 – diffuse positivity (Immunoperoxidase, ×400)

Figure 10

Immunohistochemical staining for Vimentin – strongly positive (Immunoperoxidase, ×100)

Figure 11

Immunohistochemical staining for Cytokeratin – negative (Immunoperoxidase, ×100)

Figure 12

Immunohistochemical staining for HMB 45 – weakly positive (Immunoperoxidase, ×400)

Immunohistochemical staining for S100 – diffuse positivity (Immunoperoxidase, ×400) Immunohistochemical staining for Vimentin – strongly positive (Immunoperoxidase, ×100) Immunohistochemical staining for Cytokeratin – negative (Immunoperoxidase, ×100) Immunohistochemical staining for HMB 45 – weakly positive (Immunoperoxidase, ×400)

Systemic survey

Detailed hematological and whole-body CT scanning both initially and at four-year follow-up were negative for distant metastases.

Tissue diagnosis

Spindle cell variant of the “combined form” of cutaneous desmoplastic type of amelanocytic melanoma, in vertical growth phase, with marginal clearance and probable satellitism.

Final diagnosis and staging

Considering the history of repeated attempts at its excision, microscopic finding of scar tissue around the lesions, and the histopathological as well as immunohistochemical features mentioned earlier, the final diagnosis was made as recurrent cutaneous desmoplastic melanoma with macroscopic satellitism, which, as per the new AJCC classification,[2] belongs to: Clinical stage II C (T4b N0 M0) and pathological stage III b (T4 N2C M0).

Literature Review

Conley et al. described “desmoplastic melanoma” in 1971.[3] Subsequently, a vast amount of literature was published about this rare entity. The salient features, in general, of its presentation such as site and clinical appearance, biological behaviour, histopathology and treatment recommendations were found to be common to most, if not all, of the publications, and they are mentioned below. Incidence: 1–2% of all melanomas, De Vita, 2005.[4] Race: All races, but common in Caucasians. Sex: Male : Female ratio = 1.75-2 : 1. Age: Later age group, commonest in the seventh decade of life, Jain S et al., 1989.[5]

Site

It can occur in skin and mucosa of any region of the body. More commonly reported areas of occurrence are as follows: Males: Sun-exposed areas on the head, neck, and upper part of the trunk. Females: The extremities.

Size

Tends to be bulky, many lesions are not recognized until they have reached a substantial thickness.

Category

Neurectodermal tumor, Carlson JA, 1975[6] /Neural crest tumor, Huttenbach, 2002.[7] Origin: Both from intraepidermal melanocytes as well as de novo, Carlson JA, 1995.[6] Type: Fibrosing variant of spindle cell melanoma, Busam KJ, 2005.[8]

Biological behaviour

Locally aggressive High incidence of local recurrences. Recurrences are attributed to inadequate excision of the primary lesion. History of repeated surgeries with erroneous/mistaken diagnoses. Possibility of aggressive local treatment producing cure.[9] Lymph node metastases: Rare. Distant metastases: Rare. When present, they are common in the lungs. Radiotherapy and Chemotherapy: No proved effectiveness.

Clinical features

Usually nonpigmented lesions. Often mistaken clinically for a scar, a fibroma, a basal cell carcinoma, a fleshy or firm nodule reminiscent of a scar, a sarcoma, or a dermatofibroma. Arise de novo or in association with a pre-existing lesion such as lentigo maligna, in which case, a clue to the diagnosis will be available. When de novo, they can present in an unsuspecting manner such as indurated, nonulcerated, and slightly elevated plaque, as a papule, or as a small nodule etc. Till date, to the author’s knowledge, no report exists describing it presenting as a pyogenic granuloma.

Histopathology

Microscopic features

Desmoplasia, Busam, 2005,[8] Markovic et al., 2007[10]: Spindle cells (amelanotic, fusiform, melanocytes) dispersed in a prominent collagenous or fibrous tissue stroma. The pure forms contain desmoplasia in more than 90% of the lesion. The combined or mixed forms contain desmoplasia in less than 10% of the lesion, with or without heteromorphism (presence of disparate phenotypes in a single neoplasm). The phenotypic elements include: epithelioid cells, Murali et al., 2008,[11] macrophages, smooth muscle, fibroblast-like cells, multinucleated cells, heterotopic bone, lentigo maligna epidermal component, nerve filaments, perivascular lymphoproliferation and focal lymphocytic aggregates.

Other histological features

They include ulceration, neurotropism, neuroma-like features, cytological atypia, atypical nuclei, high mitotic rate, higher mitotic index, stromal myxoid change, sarcoma-like features, individual necrotic cells, areas of myxoid or storiform appearance, infiltration of the adventitia of the blood vessels, perineurium, endoneurium or local nerves, vertical growth phase while arising in a pre-existing lesion such as a lentigo maligna, common depth of Breslow’s measurement of more than 4 mm, and satellite lesions that are usually microscopic. Diffuse positivity for S-100 and Vimentin, weak positivity or negativity for HMB 45, and negativity for Cytokeratin.

Diagnosis

Clinical presentation of “desmoplastic melanoma” is a diagnostic trap for the unwary, Mc Carthy et al., 2004.[12] The clinical and histological features of this lesion may give rise to perplexing diagnostic and therapeutic dilemmas. A high index of suspicion is warranted for its early and proper diagnosis.

Prognosis

Conventionally, the prognosis is considered poor, but it is a curable disease with aggressive local treatment alone, Arora et al., 2005.[13]

Treatment

Wide excision

It alone may be sufficient. To be effective, all the excised specimens must be biopsied, and marginal clearance must be ensured in all the excised specimens. In the absence of marginal clearance, excisional surgery must be repeated until marginal clearance is ensured. Inadequate local treatment leads to local recurrence. Repeated local recurrences can lead to increased incidence of distant metastases. Death is usually due to distant metastases.

Sentinel lymph node biopsy

It is not usually helpful.

Follow-up

A careful, long-term follow-up is mandatory.

Discussion

In the reported case, the nature of initial presentation to dermatologists and operating surgeons of the outside facility was unknown. It had recurred twice after the earlier surgeries. The simple precaution of ensuring the histological “marginal clearance” after the current surgical excision seemed to have made the difference. The local and systemic surveys that were negative at four-year follow-up suggest that, as per Lens et al., the condition can be considered as “cured”.[14] The “adjustable sutures”[1] are mattress sutures applied between the wound edges. Soft materials such as sterile dental rolls are used as bolsters. They are inserted between suture material and skin on either side of the wound, and are retained in place with a slipknot. Loosening of the slipknot, changing of the sterile dental rolls, gentle tightening of the sutures within the pain-tolerance-limit of the patient, and reapplication of the slipknot daily or on alternate days, gradually pulls the wounds’ edges. With time, the wound edges meet each other, permitting direct closure of the wounds and avoiding the need for plastic surgical procedures such as skin grafting, flaps and microsurgery.

Conclusion

In most cases, a DM is diagnosed only in established long-standing and thick melanomas. Therefore, dermatologists and dermatopathologists should be more aware of this clinicopathologic variant of cutaneous malignant melanoma, de Almeida et al., 2008.[15] Accordingly, this case was reported to increase familiarity of treating physicians with this misleading and disastrous malignancy presenting in an innocent manner; and to introduce a simple technique to close the “difficult-to-close” excisional defects that can be used by surgeons of all specialties and capacities.
  13 in total

1.  Adjustable suture technique based on viscoelastic properties of skin for direct closure of a defect after abdominoplasty flap necrosis.

Authors:  B Venkata Ratnam
Journal:  Aesthetic Plast Surg       Date:  2006 Jul-Aug       Impact factor: 2.326

2.  Desmoplastic malignant melanoma and its variants. A study of 45 cases.

Authors:  S Jain; P W Allen
Journal:  Am J Surg Pathol       Date:  1989-05       Impact factor: 6.394

3.  Desmoplastic malignant melanoma (a rare variant of spindle cell melanoma).

Authors:  J Conley; R Lattes; W Orr
Journal:  Cancer       Date:  1971-10       Impact factor: 6.860

Review 4.  Cutaneous desmoplastic melanoma.

Authors:  Klaus J Busam
Journal:  Adv Anat Pathol       Date:  2005-03       Impact factor: 3.875

Review 5.  Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis.

Authors:  Svetomir N Markovic; Lori A Erickson; Ravi D Rao; Roger H Weenig; Barbara A Pockaj; Aditya Bardia; Celine M Vachon; Steven E Schild; Robert R McWilliams; Jennifer L Hand; Susan D Laman; Lisa A Kottschade; William J Maples; Mark R Pittelkow; Jose S Pulido; J Douglas Cameron; Edward T Creagan
Journal:  Mayo Clin Proc       Date:  2007-03       Impact factor: 7.616

6.  Cytologic features of metastatic and recurrent melanoma in patients with primary cutaneous desmoplastic melanoma.

Authors:  Rajmohan Murali; Noel T Loughman; Paul R McKenzie; Geoffrey F Watson; John F Thompson; Richard A Scolyer
Journal:  Am J Clin Pathol       Date:  2008-11       Impact factor: 2.493

Review 7.  Desmoplastic melanoma: a diagnostic trap for the unwary.

Authors:  Stanley W McCarthy; Richard A Scolyer; A Allan Palmer
Journal:  Pathology       Date:  2004-10       Impact factor: 5.306

8.  Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.

Authors:  Luis Soares de Almeida; Luis Requena; Arno Rütten; Heinz Kutzner; Claus Garbe; Dinis Pestana; Manuel Marques Gomes
Journal:  Am J Dermatopathol       Date:  2008-06       Impact factor: 1.533

9.  Desmoplastic and spindle cell melanomas express protein markers of the neural crest but not of later committed stages of Schwann cell differentiation.

Authors:  Yve Huttenbach; Victor G Prieto; Jon A Reed
Journal:  J Cutan Pathol       Date:  2002-10       Impact factor: 1.587

10.  Desmoplastic neurotropic melanoma. A clinicopathologic analysis of 28 cases.

Authors:  J A Carlson; G R Dickersin; A J Sober; R L Barnhill
Journal:  Cancer       Date:  1995-01-15       Impact factor: 6.860

View more
  1 in total

1.  Lower Extremity Desmoplastic Malignant Melanoma in Egypt.

Authors:  Reham William Doss; Sahar Daoud; Alshimaa Mohamed Abbas Mostafa; Sara Abd Elrahman Mohammed
Journal:  Indian J Dermatol       Date:  2017 Sep-Oct       Impact factor: 1.494

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.